Inner Space Research is actively conducting clinical trials exploring new treatment approaches for depression, anxiety, trauma-related conditions, and other mental health challenges.
Our studies are designed to evaluate promising therapies in a structured, research-based setting with strong oversight and care.
Questions? Read our FAQ or contact our team.
LB-102-011
For adults with a diagnosis of Bipolar I Disorder currently experiencing a Major Depressive Episode (MDE).
The goal of this study is to evaluate the efficacy, safety, and tolerability of LB-102, compared to placebo, in treating depressive symptoms associated with Bipolar I Disorder.
This study is sponsored by LB Pharmaceuticals.
The purpose of this study is to determine if treatment with a single dose of RE104 reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
This study is sponsored by Reunion
This study is designed to evaluate the efficacy of a single dose of 100 µg of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of depression symptoms.
This study is sponsored by Definium Therapeutics
For adults living with Post Traumatic Stress Disorder (PTSD)
The purpose of this study is to assess the efficacy, safety, and tolerability of TSND-201 for the treatment of PTSD symptoms compared to placebo
This study is sponsored by Transcend Therapeutics, Inc.
